Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Musarra

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
European Annals of Allergy and Clinical Immunology|October 11, 2011
Allergen immunotherapy in asthma: current evidence and future requirementsE Madonini, A Musarra
European Annals of Allergy and Clinical Immunology|May 18, 2013
Antihistamines in daily practice: Italian allergologists' opinionA Musarra, G Senna, C Lombardi
European Annals of Allergy and Clinical Immunology|September 9, 2025
Pollen-induced asthma: a unique model of mild to moderate asthmaA Vaghi, M B Bilò, A Musarra
European Annals of Allergy and Clinical Immunology|July 23, 2010
Long-lasting effect of a monophosphoryl lipid-adjuvanted immunotherapy to parietaria. A controlled field studyA Musarra, D Bignardi, C Troise, et al.
European Annals of Allergy and Clinical Immunology|December 29, 2006
Survey on the safety of a no-updosing regimen of sublingual immunotherapyA Musarra, M Cilia, S Pecora, et al.
European Annals of Allergy and Clinical Immunology|June 6, 2015
Consensus on allergen specific immunotherapyA Musarra, M B Bilò, S Bonini, et al.
European Annals of Allergy and Clinical Immunology|November 15, 2024
The added value of targeting airway hyperresponsiveness by blocking TSLP in the management of severe asthmaA Vaghi, M B Bilò, F Bini, et al.
European Annals of Allergy and Clinical Immunology|October 10, 2022
From triggers to asthma: a narrative review on epithelium dysfunctionL Cecchi, A Vaghi, F Bini, et al.
Allergologia Et Immunopathologia|July 1, 1996
Rush sublingual immunotherapy in Parietaria allergic patientsF P D'Ambrosio, L Ricciardi, S Isola, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 19, 2005
Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 yearsV Di Rienzo, M Minelli, A Musarra, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Annals of Allergy and Clinical Immunology|October 11, 2011
Allergen immunotherapy in asthma: current evidence and future requirementsE Madonini, A Musarra
European Annals of Allergy and Clinical Immunology|May 18, 2013
Antihistamines in daily practice: Italian allergologists' opinionA Musarra, G Senna, C Lombardi
European Annals of Allergy and Clinical Immunology|September 9, 2025
Pollen-induced asthma: a unique model of mild to moderate asthmaA Vaghi, M B Bilò, A Musarra
European Annals of Allergy and Clinical Immunology|July 23, 2010
Long-lasting effect of a monophosphoryl lipid-adjuvanted immunotherapy to parietaria. A controlled field studyA Musarra, D Bignardi, C Troise, et al.
European Annals of Allergy and Clinical Immunology|December 29, 2006
Survey on the safety of a no-updosing regimen of sublingual immunotherapyA Musarra, M Cilia, S Pecora, et al.
European Annals of Allergy and Clinical Immunology|June 6, 2015
Consensus on allergen specific immunotherapyA Musarra, M B Bilò, S Bonini, et al.
European Annals of Allergy and Clinical Immunology|November 15, 2024
The added value of targeting airway hyperresponsiveness by blocking TSLP in the management of severe asthmaA Vaghi, M B Bilò, F Bini, et al.
European Annals of Allergy and Clinical Immunology|October 10, 2022
From triggers to asthma: a narrative review on epithelium dysfunctionL Cecchi, A Vaghi, F Bini, et al.
Allergologia Et Immunopathologia|July 1, 1996
Rush sublingual immunotherapy in Parietaria allergic patientsF P D'Ambrosio, L Ricciardi, S Isola, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 19, 2005
Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 yearsV Di Rienzo, M Minelli, A Musarra, et al.
Pageof 3